Abstract
Colorectal cancer patients with ≤10 unresectable metastases were treated with single-fraction sub-ablative radiotherapy in addition to standard of care systemic therapy in a single-arm, open-label, multicenter, pilot study (SIRIUS) to assess feasibility and safety. Results indicate that radiotherapy combined with systemic therapy is feasible and safe in this population.
Original language | English |
---|---|
Article number | 100874 |
Pages (from-to) | 1-5 |
Number of pages | 5 |
Journal | Clinical and translational radiation oncology |
Volume | 49 |
DOIs | |
Publication status | Published - Nov 2024 |
Keywords
- Oligometastases
- phase I
- SBRT
- Single fraction
- Systemic therapy